Reviews

Resistance exercise interventions during and following cancer treatment: a systematic review


 

Findings from prior systematic reviews suggest that exercise results in meaningful improvements in many clinically relevant physiologic and quality of life (QoL) outcomes during and following cancer treatment. However, the majority of exercise-cancer studies have focused upon the benefits of aerobic exercise (AE) and knowledge of the efficacy of resistance exercise (RE) alone as a supportive care intervention for cancer patients and survivors remains limited. Consequently, the purpose of this review was to provide the first systematic evaluation of the effects of RE alone upon clinically relevant physiologic and QoL outcomes during and following cancer treatment. Literature searches were conducted to identify studies examining RE interventions in cancer patients and survivors. Data were extracted on physiologic (fitness, physical function, and body composition) and QoL (fatigue, psychological well-being, and cancer-specific and global QoL outcomes. Cohen’s d effect sizes were calculated for each outcome. A total of 15 studies (6 in samples undergoing active cancer treatment and 9 in samples having completed cancer treatment) involving 1,077 participants met the inclusion criteria. Findings revealed that, on average, RE resulted in large effectsize improvements in muscular strength (d 0.86), moderate effect-size improvements in physical function (d 0.66), and small effect-size improvements in body composition (d 0.28) and QoL (d 0.25) outcomes. The effect sizes observed following RE are comparable in magnitude to the effects of exercise interventions reported in prior comprehensive reviews of the exercise cancer literature which primarily focused upon AE. Additionally, the methodologic quality of the studies was generally strong. Taken collectively, results of this systematic review suggest that RE is a promising supportive care intervention that results in meaningful improvements in clinically relevant physiologic and QoL outcomes during and following cancer treatment.

Click on the PDF icon at the top of this introduction to read the full article.

Recommended Reading

Agencies continue push for indoor tanning regulations
MDedge Hematology and Oncology
What's in a name: Is the moniker 'palliative care' too loaded?
MDedge Hematology and Oncology
Prescription is futile: Medication burden remains high at end of life
MDedge Hematology and Oncology
Compounding the woes of cancer patients
MDedge Hematology and Oncology
Cancer patients embrace pioneer assisted-suicide program
MDedge Hematology and Oncology
Dexamethasone eases end-of-life cancer-related fatigue
MDedge Hematology and Oncology
USPSTF draft recommendations update chemoprevention for breast cancer
MDedge Hematology and Oncology
SPIKES protocol offers guidance for 'active listening' when talking to cancer patients
MDedge Hematology and Oncology
Weight loss, exercise can impact cancer incidence and recurrence
MDedge Hematology and Oncology
Timely palliative consult affects end-of-life care in gynecologic cancer patients
MDedge Hematology and Oncology